Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of GnRH Antagonist Administration in the Treatment of Early Ovarian Hyperstimulation Syndrome

NCT01268761 is registered in ClinicalTrials.gov with Instituto Valenciano de Infertilidad, IVI VALENCIA as lead sponsor.

NCT NCT01268761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01268761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of GnRH Antagonist Administration in the Treatment of Early Ovarian Hyperstimulation Syndrome
Lead sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2012
Completion date
July 31, 2013
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effects of gonadotropin, oocyte maturation, ovarian hyperstimulation syndrome